Who owns Candel Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CADL from SEC Form 13F filings across 137 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 137 institutions disclosed 50.4M shares of Candel Therapeutics, Inc. worth $518.9M — about 68% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
137
13F holders
$518.9M
value, 2026 filers
68%
of shares outstanding (50.4M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CADL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 11.0M | $113.2M | 0.0% | 14.8% | 0.0% |
| 2 | RTW INVESTMENTS, LP | 6.4M | $66.1M | 0.6% | 8.7% | 0.0% |
| 3 | BlackRock, Inc. | 5.0M | $51.2M | 0.0% | 6.7% | +59.8% |
| 4 | STATE STREET CORP | 3.5M | $36.6M | 0.0% | 4.8% | +333.7% |
| 5 | ACORN CAPITAL ADVISORS, LLC | 3.5M | $36.0M | 9.8% | 4.7% | 0.0% |
| 6 | Portolan Capital Management, LLC | 3.5M | $36.0M | 1.3% | 4.7% | +20.6% |
| 7 | Saturn V Capital Management LP | 3.3M | $34.0M | 4.9% | 4.5% | +14.1% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $27.7M | 0.0% | 3.6% | +9.4% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $16.2M | 0.0% | 2.1% | +51.7% |
| 10 | MILLENNIUM MANAGEMENT LLC | 1.1M | $11.3M | 0.0% | 1.5% | +3.2% |
| 11 | Halter Ferguson Financial Inc. | 772,461 | $8.0M | 1.3% | 1% | -14.6% |
| 12 | NORTHERN TRUST CORP | 492,465 | $5.1M | 0.0% | 0.7% | +52.4% |
| 13 | KENNEDY CAPITAL MANAGEMENT LLC | 488,291 | $5.0M | 0.1% | 0.7% | +427.2% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLC | 437,150 | $4.5M | 0.0% | 0.6% | +63.0% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 412,109 | $4.2M | 0.0% | 0.6% | +46.9% |
| 16 | Sands Capital Alternatives, LLC | 405,837 | $4.2M | 0.7% | 0.5% | 0.0% |
| 17 | GOLDMAN SACHS GROUP INC | 305,216 | $3.1M | 0.0% | 0.4% | +34.1% |
| 18 | MARSHALL WACE, LLPNEW | 300,641 | $3.1M | 0.0% | 0.4% | new |
| 19 | BANK OF AMERICA CORP /DE/ | 278,944 | $2.9M | 0.0% | 0.4% | +488.5% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 227,939 | $2.3M | 0.0% | 0.3% | +101.8% |
| 21 | WELLINGTON MANAGEMENT GROUP LLPNEW | 205,745 | $2.1M | 0.0% | 0.3% | new |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 199,454 | $2.1M | 0.0% | 0.3% | +78.5% |
| 23 | Tanager Wealth Management LLP | 198,175 | $2.0M | 0.2% | 0.3% | 0.0% |
| 24 | Bank of New York Mellon Corp | 191,701 | $2.0M | 0.0% | 0.3% | +40.7% |
| 25 | UBS Group AG | 169,271 | $1.7M | 0.0% | 0.2% | +13.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.